Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Divi's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532488
ISIN Demat	INE361B01024
Book Value	600.79

NSE Code	DIVISLAB
Dividend Yield %	0.47
Market Cap	1679752.44

P/E	66.71
EPS	94.85
Face Value	2


	BSE		NSE

06-Mar-2026

Last Price	6327.50
Net Change	-36
% Change	-0.57%
Prev.Close	6363.50
Open	6363.50
High	6426.00
Low	6251.20
Volume	31229

Last Price	6329.00
Net Change	-35.5
% Change	-0.56%
Prev.Close	6364.50
Open	6340.00
High	6428.00
Low	6315.00
Volume	269349

Value	199565816
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	6426.00
52-Week High	7077.70
52-Week Low	4941.70

Value	1719098991.5
Best Buy	0.00
Best Sell	6329.00
Best Quantity	0
Sell Quantity	6
Today's Range	6428.00
52-Week High	7071.50
52-Week Low	4955.00

Open Price	6351.00
High Price	6449.00
Low Price	6339.00
Last Price	6351.50
Prev Close	6392.50
Change	-41.00
% Change	-0.64 %

Average Price	6404.38
Underlying Value	6329.00
Number of contracts traded	2944
Turnover in Rs. Lakhs	18854
Open Interest	2726800.00
Change in O I	13500.00
% Change in O I	0.50 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	6
Price	6329.00

Best Bid

Best Offer

Quantity	100
Price	6353.5

Quantity	100
Price	6362.5

Holding Details

Latest Corporate Events

Bonus

1 : 1

23-Sep-15

Book Closure

20-Aug-21

22-Aug-21

Dividend

1500 %

25-Jul-25

Company News

30-01-2026

Divis Laboratories inform...

03-01-2026

Divi's Laboratories infor...

31-12-2025

Divi’s Laboratories infor...

10-11-2025

Divi's Laboratories repor...

12-08-2025

Divi's Laboratories infor...

07-08-2025

Divi’s Laboratories repor...

07-08-2025

Divis Laboratories inform...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.